Alethia Biotherapeutics Announces Issuance of a Japanese Patent for …MarketWatch (press release)MONTREAL, QUEBEC, Feb 19, 2013 (MARKETWIRE via COMTEX) — Alethia Biotherapeutics Inc., a privately held biotechnology company focusing on the development…
Alethia Biotherapeutics Announces Issuance of a Japanese Patent for …Marketwire (press release)19, 2013) – Alethia Biotherapeutics Inc., a privately held biotechnology company focusing on the development of therapeutic monoclonal antibodies, announce…
|
Doctors’ Column: New drug may help with MS symptoms
ReporterNews.com However, researchers at the National Institutes of Health have discovered that the drug daclizumab appears to tone down the autoimmune response in MS patients, providing hope for those trying to overcome the obstacles of living with MS. MS is an … |
Addition of rituximab to chlorambucil failed to improve OS in MALT lymphomaHealioResearchers compared chlorambucil (Leukeran, Aspen Global) alone with chlorambucil and rituximab (Rituxan, Genentech/Idec Pharmaceuticals) as initial therapy in a cohort o…
The Biological SCENENew Starting Point For Flu Drug DesignThe Biological SCENEHuman antibodies interact with H2 hemagglutinin by inserting an aromatic residue (yellow) into the sialic acid-binding pocket. Credit: Rui Xu/Scripps Research Institute. The …
|
John Maunder gets ready for Yuleba World’s Greatest Shave
Warwick Daily News “It involves 8 treatments of fortnightly ABVD chemotherapy and a fortnightly dose of an antibody called Rituximab which targets the cancerous cells,” he said. “This will most likely be followed with involved-field radiotherapy which last a couple of … |
|
John Maunder gets ready for Yuleba World’s Greatest Shave
Toowoomba Chronicle “It involves 8 treatments of fortnightly ABVD chemotherapy and a fortnightly dose of an antibody called Rituximab which targets the cancerous cells,” he said. “This will most likely be followed with involved-field radiotherapy which last a couple of … |
|
ABT-199 Clinical Trial Suspended (Updated)
Corante Update: I’ve had email from the company, clarifying things a bit: “While AbbVie has voluntarily suspended enrollment in Phase 1 trials evaluating ABT-199 as a single agent and in combination with other agents such as rituximab, dosing of active … |
|
Taking a Snapshot of the Human Immune System
GovExec.com Using high throughput sequencing technology, the team characterized every single antibody, from each volunteer, at each of the three time points—that’s 5 million antibodies! They noted the types of antibodies present (there are five possible types … Dreams of ideal flu vaccine are closer to realityMedical Xpress |
 Europa Press |
Medicamento Rituximab es más efectivo que terapia estándar en Linfoma
Comunicado-Prensa.com (Comunicado de prensa) El medicamento Rituximab, de Roche, y la bendamustina son más “eficaces y menos tóxicos” que la terapia estándar R-CHOP en el tratamiento del linfoma no Hodgkin. Así lo asegura un estudio de la Universidad de Giessen (Alemania). El estudio … Empresas.- El tratamiento del linfoma no Hodgkin indolente con bendamustina y …Europa Press |